Investment
Features
FeesSafety
Academy
More
Pluang+

ARK Invest buys $251K in BitMine and 3iQ Solana Staking ETF to boost crypto exposure

Market News
25 Jul 2026
Crypto news
View Source
Bullish
ARK Invest buys $251K in BitMine and 3iQ Solana Staking ETF to boost crypto exposure

ARK Invest added about $251,500 in shares of BitMine Immersion Technologies and the 3iQ Solana Staking ETF across three of its ETFs, increasing its crypto-related holdings. The ARK Innovation ETF bought 5,264 BitMine shares worth $83,100, while the ARK Next Generation Internet and Fintech Innovation ETFs acquired 28,018 shares of the Solana staking ETF valued at $168,400. These moves reflect ARK's strategy to gain crypto exposure through public equities and ETFs rather than direct token purchases, amid ongoing portfolio adjustments in AI, healthcare, and technology sectors. Investors should see this as part of ARK's broader thematic investment approach, not a direct forecast on these assets.

More News

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
59 minutes ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
59 minutes ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
59 minutes ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
1 hour ago
Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.

Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.

The global anthracite market, valued at $11.9 billion in 2025, is projected to grow to $16.8 billion by 2035 with a 3.5% CAGR. Growth is fueled by rising demand in steel production, water filtration, and advanced industrial uses due to anthracite's h...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App